Eversight [Clark / United States of America]

Eversight [Clark / United States of America] located in CLARK NJ, United States of America had its last known inspection on 18 Aug 2022. There are 10 known inspections on record.

Site Details

Industries:
Biologics
Tags:
Biologics, Vaccines, Biologics: HCT/P, Human Cellular, Tissue, and Gene Therapies
Last Inspection Date:
18 Aug 2022
FEI:
3001236615
Redica ID:

Eversight [Clark / United States of America]'s Most Recent Documents

Publish Date Document Type Title
February, 2019 FDA 483 Eversight - Form 483, 2019-02-19

Experience Redica Systems’s NEW site dashboards and profiles

Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Loading...

Site Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more